Medpace Holdings, Inc. Long-Term Debt
Medpace Holdings, Inc. (MEDP) had Long-Term Debt of $0 as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebtNoncurrent · last filed 2020-02-25
- 2019-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2019-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2019-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2019-03-31: Long-term Debt, Excluding Current Maturities $55.78M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-25 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-29 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-30 |
| 2019-03-31 | $55.78M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $79.72M 10-K · filed 2020-02-25 |
| 2018-09-30 | $113.69M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $147.02M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $181.07M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $205.11M 10-K · filed 2019-02-26 |
| 2017-09-30 | $169.15M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $143.19M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $147.23M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $151.27M 10-K · filed 2018-02-27 |
| 2016-09-30 | $154.61M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $377.88M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |